Home » Biotech » biotechnology » dementia » drug development » drug prices » finance » Health » Human Health » Life Sciences » Medicine » Pharma » Pharmaceuticals » research » Science and Research » The Readout » As Pfizer slashes revenue projections, Moderna says it “remains comfortable”

As Pfizer slashes revenue projections, Moderna says it “remains comfortable”

October 17, 2023 STAT Off Biotech, biotechnology, dementia, drug development, drug prices, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the latest twist in the GLP-1 saga, some drama in the world of Covid-19 booster shots, and the debut of the 2023 STAT Wunderkinds.

Read the rest…

Read Original Article: As Pfizer slashes revenue projections, Moderna says it “remains comfortable” »

About The Author

STAT